Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -162.87% is in line with its 5-year average of -166.20%, around the middle of its 5-year range (-526.04%–0.00%).
13.35% above its 12-month average of -187.96%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -170.31%.
OPERATING MARGIN
-162.87%
OPERATING MARGIN AVG TTM
-187.96%
OPERATING MARGIN AVG 3Y
-222.15%
OPERATING MARGIN AVG 5Y
-166.20%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+13.35%
CURRENT VS 3Y AVG
+26.69%
CURRENT VS 5Y AVG
+2.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
20/20 Biolabs Inc.
Market Cap
$4.44M
Operating Margin
-162.87%
TTM Avg
-187.96%
3Y Avg
-222.15%
5Y Avg
-166.20%
Market Cap
$4.27M
Operating Margin
-484.31%
TTM Avg
-1917.01%
3Y Avg
-2405.16%
5Y Avg
-1618.57%
Market Cap
$4.11M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.55M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.97M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-229.94%
5Y Avg
-288.65%
Market Cap
$4.67M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.71M
Operating Margin
-1128.11%
TTM Avg
-14522.19%
3Y Avg
-8776.16%
5Y Avg
-5850.77%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 20/20 Biolabs Inc. (AIDX) | $4.44M | -162.87% | -187.96% | -222.15% | -166.20% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.27M | -484.31% | -1917.01% | -2405.16% | -1618.57% |
| GRI Bio, Inc. (GRI)vs › | $4.13M | N/A | 0.00% | 0.00% | -243.17% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.97M | 0.00% | 0.00% | -229.94% | -288.65% |
| CalciMedica, Inc. (CALC)vs › | $4.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.71M | -1128.11% | -14522.19% | -8776.16% | -5850.77% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.85M | -774.90% | -1185.31% | -1296.90% | -883.94% |
Gross Margin
31.5%
Operating Margin
-162.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -170.31% |
| 2026-03-31 | -408.45% |
| 2025-12-31 | -169.59% |
| 2025-09-30 | -191.44% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | -232.05% |
| 2024-09-30 | -523.66% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | -526.04% |
| 2023-03-31 | -437.63% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
